Erectile Dysfunction

"We still think that is the life blood of this company, and we don't see walking away from that," he said.

Lilly now expects full-year adjusted earnings per share to fall within the range of $3.30 to $3.40 per share, an increase from the $3.25 to $3.35 range it had projected.

"We are delivering on our priorities with solid financial performance in the first quarter," Rice told analysts during the conference call.

Print This E-mail This MORE BUSINESS • Shares drop on Quest sales deal • New drugs in the works in battle vs.

hepatitis C • Checklist for an interim boss • More Stories © 2007 The Star-Ledger.

Used by NJ.com with permission.

INSIDE Business » American Biz Daily » Market Updates » NewsFlash » Newspapers Site Tools E-mail This Print This Search Site Newsletters Speak Up!

• Talk About Business • More News Forums BUSINESS LINKS • New Jersey Chamber of Commerce An Advertising Section » Search for Colleges and Schools » Fun Guide: Things to do in NJ » Autos: Free price quote on new vehicles » Cool Contests and Giveaways STAR-LEDGER » Premier Estates » Active Adult Community » Bridal Planner » Bride and Groom » Circle of Excellence » Outlook III - Consumer...

Read more...